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Abstract 
Diabetes mellitus is generally associated with a higher incidence of early pregnancy loss and 
congenital anomalies, though this relationship should be strictly restricted to patients with previously 
existing diabetes. In gestational diabetes mellitus, which often develops during the third trimester, no 
such relationship should exist, though the birth of a previous infant with a congenital anomaly is 
often assumed to be a risk factor for gestational diabetes. 
Objective: The study attempts to analyse the congenital anomaly rate in women with gestational 
diabetes and compare this to the rates in women known to have normal glucose tolerance. 
Results: The prevalence of infants/fetuses with congenital anomalies born to women with gestational 
diabetes amounted to 4.48%, a rate similar to that recorded in women with normal glucose tolerance 
(4.54%). 
Conclusions: The development of gestational diabetes, in contrast to pre-existing diabetes, does not 
appear to be associated with an increased risk for teratogenesis. 
© 2004 Elsevier Ireland Ltd. All rights reserved. 
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1. Introduction 
Evidence demonstrates that women with diabetes mellitus have a greater risk of 
spontaneous abortions and congenital malformations. This risk in women with pre-existing 
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DM has been associated to poor glycaemic control during the embryonic period, 
particularly in the first few weeks after conception. A similar risk has been desclibed for 
women who develop gestational diabetes later on in the pregnancy suggesting that the 
mechanism for embryonal dysfunction may involve a genetic or hormonal predisposition 
[1]. Similar increased risks for early pregnancy loss (x5.5-fold increase) and teratogenesis 
(x 1.6-fold increase) have been previously observed in Maltese pregnant women who 
develop gestational diabetes [2]. The Maltese population in the Central Mediterranean has 
been repeatedly shown to have a high prevalence of carbohydrate metabolism problems, 
which is reflected in the pregnant population [3]. The present study attempts to identifY 
whether gestational diabetes is truly a risk factor for the development of congenital 
anomalies in a relatively closed popUlation with a high prevalence of NIDDM. 
" 
2. Material and methods 
All pregnant women (n=1263) undergoing a 75-g oral glucose tolerance test [oGTT] in 
the third tlimester at St. Luke's Teaching Hospital (Malta) duling the peliod 1996-2000 
were included in the study. An oGTT is generally performed on women identified as being 
at risk of GDM on the basis of standard "historical-clinical" risk factors, the test being 
generally performed in the late second or the third tlimester of pregnancy. In our 
experience, this screening procedure identifies all the cases of severe GDM [2-h value 
211.0 mmol/l] and about 20% mild GDM [2-h value 8.6=10.9 mmolll] [2]. The majOlity 
of the women were lost to postnatal follow-up, however none of the patients had evidence 
of significant recurrent first or early second tlimester glycosuria. This study popUlation 
included 972 women with normal glucose tolerance, and 291 women with oGTT glucose 
values in line with the recommendations made by the Amelican Diabetes Association. The 
infant outcome of the current pregnancy of these patients was traced from the Malta 
Congenital Anomalies Register kept by the Department of Health Information (Malta) that 
registers all infants or fetuses with malformations born on the Maltese Islands since 1993. 
Statistical significance was tested using the Chi-square test analysis was using MedCalc 
(ver.4.l6) statistical package. A probability value of <0.05 was taken to represent a 
significant correlation. The work was approved by the Ethics Committee of the Faculty of 
Medicine and Surgety of the University of Malta. The subjects gave informed consent to 
the collection of the databases and the data analysis. 
3. Results 
The prevalence of infants/fetuses born with one or more anomalies to women with 
gestational diabetes mellitus during 1996-2000 was estimated at 4.54%, while that in 
women with normal glucose tolerance was estimated at 4.48% (Table 1). The small 
difference was not statistically significant (p=0.9066, contingency coefficient=0.003). The 
overall prevalence of congenital anomalies in the study population (4.74%) was higher 
though not statistically significant (p=0.1692, contingency coefficient=0.007) than that 
registered in the Maltese Islands duling the period 1993-2000 (3.74%). 
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Table I 
Congenital anomalies incidence rates by carbohydrate tolerance status 
Anomalies present Normal present Rate of infants/fetuses 
pregnancy pregnancy with anomalies (%) 
• Normal tolerance 44 928 4.54 
• Gestational diabetes 13 278 4.48 
Total 57 1206 4.74 
Total population 1993-2000 1408 36,224 3.74 
The commonest type of abnormality noted in the study group was cardiovascular 
defects which accounted for 64.7% in women with abnormal carbohydrate metabolism 
and 54.7% in women with normal carbohydrate metabolism (Table 2). The differences 
were however not statistically significant (p=0.4623, contingency coefficient=O.075). 
When compared to the overall population pattern of the types of congenital malformations 
reported in the Maltese Islands during the period, it would appear that cardiovascular 
anomalies in women diagnosed as suffering from GDM [n=22; 64.7%] were more 
frequent than the number reported in the general population [n=583; 42.3%], the 
difference being statistically significant (p=O.0167, contingency coefficient=O.065). The 
congenital heart defects in babies of women with GDM included 11 cases of Atrial Septal 
Defect Ostium Secundum Type; 5 cases of Ventricular Septal Defect; 2 cases of Anomalies 
of Pulmonary Valve; 2 cases of Patent Ductus Arteriosus; 1 case of Coarctation of Aorta 
and 1 case registered as Other Malformations of the Heart. The other types of anomalies 
did not show any statistically significant difference in relative frequency rates. 
Table 2 
Type of congenital anomalies by carbohydrate tolerance status [includes cases with multiple lesions] 
Malformation type Abnormal oGTT NormaloGTT Statistical 
significance 
ICD code No. % No. % p value 
7400-7420 Neural tube defects 0 0.00 1.56 0.7519 
7421-7429 Other anomalies of nervous system 2.94 1.56 0.7756 
7430-7449 Eye, ear, face and neck 2.94 1.56 0.7756 
7450-7479 Cardiovascular system 22 64.71 35 54.69 0.4623 
7480-7489 Respiratory system 0 0.00 0 0.00 
7490-7493 Cleft lip/palate 0 0.00 3 4.69 0.5062 
7500-7509 Upper alimentary tract 0 0.00 1.56 0.7519 
7510-7519 Other digestive system 2 5.88 4 6.25 0.7129 
7520-7529 Genital organs 0 0.00 1.56 0.7519 
7530-7539 Urinary system 2.94 1.56 0.7756 
7540-7559 Musculoskeletal system 2 5.88 5 7.81 0.9539 
7560-7569 Other musculoskeletal 0 0.00 1.56 0.7519 
7571-7579 Integument 2.94 1.56 0.7756 
7580-7589 Chromosomal anomalies 2 5.88 4 6.25 0.7129 
7593-7599 Other congenital anomalies 0 0.00 3 4.69 0.5062 
7607-7786 Conditions in perinatal period 0 0.00 2 3.13 0.7756 
Miscellaneous 2 5.88 0 0.00 0.2314 
Total 34 100.00 64 100.00 
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4. Discussion 
A growing body of evidence has suggested an increased risk of embryonic 
development problems in the conceptus of diabetic mothers. The risk of early pregnancy 
loss and teratogenesis in women with pre-existing diabetes has been clearly demonstrated 
and has been attributed to poor glycaemic control during the embryonic period [1,4]. 
Surprisingly, similar elevated risks for teratogenesis have been described in women who 
develop gestational diabetes later on during their pregnancy and whose glycaemic control 
in the first trimester was in no way disrupted. The 1977-1981 Northwestern University 
Medical Centre (USA) study demonstrated a 4.5-fold increase in anomalies in infants of 
IDDM mothers and also a two-fold increase in birth defects in women suffering from 
gesta,!ional diabetes [5]. In the Maltese population, women with gestational diabetes were 
shown to have a non-statistically significant 1.6-fold increased risk of having a congenital 
anomaly. In addition, these women had a statistically significant 5.5-fold increased risk of 
having a history of previous early pregnancy loss [2]. The apparent association of early 
pregnancy dysfunction causing early pregnancy loss and teratogenesis in women who 
develop gestational diabetes and whose glycaemic status in the embryonic period is well 
maintained suggests that other mechanisms other than metabolic derangements may be 
playa role in the aetiology. The possibility of a "diabetic gene" responsible for an increase 
in malformations in infants of diabetic mothers has been raised, even though the evidence 
from epidemiological and animal studies suggests otherwise [1]. 
The present study has failed to identify any significant increased risk between 
teratogenesis and gestational diabetes. The previously reported statistically nonsignificant 
higher anomaly risk in GDM Maltese women may have been simply the result of study 
design and study population size. The present study shows an apparently increased 
anomaly rate in the study popUlation when compared to the National data. It is probable 
that this apparent higher rate is due to bias caused by a greater likelihood that elderly 
women with antenatal problems, including a diagnosis of malformation, undergo 
screening for DM with a glucose tolerance test. Similarly, the noted apparent higher 
frequency of anomalies of the cardiovascular system in the infants of women diagnosed as 
suffering from GDM when compared to the overall popUlation may be due to the increased 
screening that infants of GDM mothers receive. These infants are often transferred to the 
Special Care Baby Unit in the early neonatal period, where specialized medical staff is 
more likely to identifY minor cardiovascular lesions that are proven to be of no clinical 
significance and that disappear spontaneously after a few days. The large majority of 
anomalies noted in the study population referred to such minor lesions. Another possibility 
for the noted higher prevalence of cardiac defects may be that the minor biochemical 
alterations that are known to occur in infant of GDM mothers delay the conversion from a 
fetal cardiovascular system to a neonatal one. There is however to date no proof that the 
known associated biochemical alterations may in fact be responsible. 
The lack of association between teratogenesis and subsequent development of 
gestational diabetes suggests that the reported high early pregnancy loss in women who 
subsequently develop gestational diabetes is probably unrelated to any inherent heritable 
factors. There may have been some bias in the observations since in our experience the 
screening method in force only identifies about 20% of the mild cases of GDM [2-h value 
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8.6-10.9 mmolll], these cases being then considered as having a nonnal metabolic profile. 
A possible postulate for the relationship between a higher risk for early fetal loss and 
gestational diabetes could be the relationship between spontaneous abortions, polycystic 
ovarian disease and insulin resistance. Women with polycystic ovarian disease [PCOD] are 
generally infertile, but when pregnancy is achieved this is more likely to tenninate in a 
spontaneous abortion. The higher abortion rates have been correlated to the high basal 
concentrations of lutenizing honnone that inhibits the oocyte maturation inhibitor leading 
to premature reactivation of meiosis, karyotypic abnonnalities and embryo-fetal loss. In 
spite of the large increase in insulin secretion observed during pregnancy, patients with 
PCOD have been shown to develop during their pregnancy a derangement of glycaemic 
control probably related to their pregestational insulinemic status [6,7]. 
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